The signaling pathways and therapeutic potential of itaconate to alleviate inflammation and oxidative stress in inflammatory diseases

• Published in: Redox biology Vol. 58; p. 102553
• Main Authors: Shi, Xuan, Zhou, Huanping, Wei, Juan, Mo, Wei, Li, Quanfu, Lv, Xin
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.12.2022; Elsevier
• Subjects: Antioxidant therapeutics; COVID-19; Humans; Inflammation; Inflammation - drug therapy; Inflammation - metabolism; IRG1; Itaconate; Kelch-Like ECH-Associated Protein 1 - metabolism; Macrophages - metabolism; Metabolism; NF-E2-Related Factor 2 - metabolism; Oxidative Stress; Research Paper; Signal Transduction; COVID-19; Itaconate; IRG1; Inflammation; Antioxidant therapeutics; Metabolism
• ISSN: 2213-2317; 2213-2317
• DOI: 10.1016/j.redox.2022.102553

Endogenous small molecules are metabolic regulators of cell function. Itaconate is a key molecule that accumulates in cells when the Krebs cycle is disrupted. Itaconate is derived from cis-aconitate decarboxylation by cis-aconitate decarboxylase (ACOD1) in the mitochondrial matrix and is also known as immune-responsive gene 1 (IRG1). Studies have demonstrated that itaconate plays an important role in regulating signal transduction and posttranslational modification through its immunoregulatory activities. Itaconate is also an important bridge among metabolism, inflammation, oxidative stress, and the immune response. This review summarizes the structural characteristics and classical pathways of itaconate, its derivatives, and the compounds that release itaconate. Here, the mechanisms of itaconate action, including its transcriptional regulation of ATF3/IκBζ axis and type I IFN, its protein modification regulation of KEAP1, inflammasome, JAK1/STAT6 pathway, TET2, and TFEB, and succinate dehydrogenase and glycolytic enzyme metabolic action, are presented. Moreover, the roles of itaconate in diseases related to inflammation and oxidative stress induced by autoimmune responses, viruses, sepsis and IRI are discussed in this review. We hope that the information provided in this review will help increase the understanding of cellular immune metabolism and improve the clinical treatment of diseases related to inflammation and oxidative stress. [Display omitted]